Accelerate your oncology clinical development program.

0 +
0 +

Full-service solutions to meet all your needs.

From early phase conceptualization through commercialization, our teams have the expertise and solutions to advance your program. Whether you’re looking for support for your global Phase 3 trial, need a consultation on your study design, or want to transition your study, we can help.

Complex oncology trials are our specialty.

We face the complexities of oncology drug development and the highly competitive landscape head-on. Our flexible and adaptable methodology allows us to implement complex study designs well and drive better outcomes across tumor types.

Your priority is our priority.

We give you and your trial our full attention every step of the way. Our scientific, strategic, and operation experts are resource-dedicated to oncology development and are accessible when you need us, and our senior leadership is available for additional support. We’re focused on providing you with the best solutions to advance your trial and get your treatment to patients faster.

Expertise You Can Rely On

Icon list

Our teams are experienced in diverse treatment modalities and utilize a modality-specific, strategic, biomarker-driven approach. From targeted therapies and cell and gene therapies to radiopharmaceuticals, we tailor our strategies to the unique demands of each program, fully supporting our sponsors in their quest for breakthroughs.

Icon list

Though we are global, our teams are local. We have dedicated teams across the world — including in APAC, MENA, and the EU — that are skilled at providing you with local regulatory expertise and support. With an understanding of local standards of care, knowledge of regulations across agencies, and established site relationships across the globe, we can provide truly global services with the local support you need.

Icon list

When we work with sites, we aim to build real relationships that support better development. Our medical monitors and global project leads work closely with sites to provide the support they need to recruit and retain patients and collect quality data. And our project teams’ understanding of the therapies, the competitive landscape, and the patient journey means sites have like-minded support from a team well-versed in the program.

Icon list

We’re focused on increasing access to investigational treatments and reaching patients beyond academic hubs. Our recruitment and retention strategies employ innovative methods to reach patients, and we leverage patient-centered strategies to reduce the burden on families and patients to participate. We also incorporate the patent voice into our trials and, when applicable, utilize patient-reported outcomes to drive better results.

Our Experts

Worldwide Clinical Trials is focused on design and appropriate execution and reporting of clinical trial data. The mission is pretty clear…When you deal with big CROs, if we make a change in a process because we think that’s the right thing to do, it’s not enough for them just to do it because we want it. They’re less concerned about that at Worldwide…they’re more concerned about doing the right thing.

Small Biopharmaceutical Customer Director of Clinical Operations

Worldwide is an important partner for us. We have a long history with positive experiences so the relationship is on a fantastic foundation. We also believe in the value of long-term, strategic partnerships and certainly see Worldwide as one of our few strategic partners in the future.

Mid-size Biotech Customer Sr. Director of Clinical Operations

We really appreciate the strong collaborative partnership we’ve developed with Worldwide which is based on shared accountability. I see us awarding them more studies in the future.

Sr. Vice President of Clinical Development and CMS Clinical Stage Biotech Company

Awards

On May 1st, Industry Standard Research (ISR) announced the 2024 Leadership Awards, recognizing Phase 2/3 CROs for comprehensive excellence across their capabilities, compatibility, expertise, quality, and reliability.

In 2023, Worldwide Clinical Trials was named Most Innovative Clinical Research Organization (CRO) by the Triangle Business Journal (TBJ). This awards program celebrates the achievements of individuals and companies making critical advancements in pharmaceuticals, biotech, ag tech, and beyond, in the Triangle region of North Carolina.

Worldwide Clinical Trials, Inc., (Worldwide) the industry’s leading global, midsize, full-service contract research organization (CRO), has been recognized for excellence and honored in five categories in the 2022 CRO Leadership Awards, based on primary market research from Industry Standard Research (ISR) Reports and presented by Clinical Leader and Life Science Leader magazines. This marks the ninth consecutive year that Worldwide has been recognized as a high-performing CRO based on direct survey feedback from pharmaceutical and biotech professionals.

Over 80% of respondents agreed that midsize CROs provide a strong cultural fit while being able to pivot quickly based on changing customer needs.